Medical robotics start-up Robocath said today it has raised $5.2 million (EU €4.7 million) in a new round of funding.

The round was led by M Capital and Normandie Participations and joined by previous investors Go Capital and NCI, the Rouen, France-based company said.

Robocath is developing the R-one robotic platform designed for interventional cardiology, and is currently pursuing CE Mark approval in the European Union for the system.

The R-one platform is designed to allow the operating physician to remotely control their instruments from a control panel close to the operating table, the company said.  The system includes the company’s R-grasp tool for reproducing hand movement and SecurAccess system designed for stability and security.

“The whole team and I would like to thank our historical shareholders, Go Capital and NCI, for their renewed support, our bank partners BNP Paribas and La Caisse d’Epargne, and our new institutional shareholders for their strong buy-in to our plans. This new funding will help us to achieve a decisive milestone in our development strategy. R-one is currently the only robotic assistance platform for interventional cardiology developed in Europe. We plan to build on this technological edge to enter the European market next year. Given our many strengths, we will also continue to design sophisticated robotics solutions, helping to usher in a new era of medicine to benefit physicians and patients,” founder & chair Philippe Bencteux said in a prepared statement.